Related references
Note: Only part of the references are listed.Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)
Milan J. Sonneveld et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
Mireia Garcia-Lopez et al.
JOURNAL OF HEPATOLOGY (2021)
Temporal and geographic spreading of hepatitis B virus genotype A (HBV-A) in Brazil and the Americas
Jonas Michel Wolf et al.
JOURNAL OF VIRAL HEPATITIS (2021)
APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients
Jia-Horng Kao et al.
HEPATOLOGY INTERNATIONAL (2021)
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)
Grishma Hirode et al.
GASTROENTEROLOGY (2021)
Prospective Study of Withdrawal of Antiviral therapy in Patients with Chronic Hepatitis B after Prolonged Virological Response
Naveen Gara et al.
HEPATOLOGY COMMUNICATIONS (2021)
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)
Kin Seng Liem et al.
GUT (2019)
Systematic review with meta-analysis: combination treatment of regimens based on pegylated interferon for chronic hepatitis B focusing on hepatitis B surface antigen clearance
K. Qiu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B
Wen-Juei Jeng et al.
HEPATOLOGY (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B
George Papatheodoridis et al.
ANTIVIRAL THERAPY (2018)
Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study
Thomas Berg et al.
JOURNAL OF HEPATOLOGY (2017)
Off-Treatment Hepatitis B Virus (HBV) DNA Levels and the Prediction of Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B: A Prospective Stop Study
Jiawei Cao et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance
F. Liu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Combination of Tenofovir Disoproxil Fumarate and Peginterferon alpha-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Patrick Marcellin et al.
GASTROENTEROLOGY (2016)
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion
Juliana Bruder Costa et al.
PLOS ONE (2016)
Ten-year follow-up of hepatitis B relapse after cessation of lamivudine or telbivudine treatment in chronic hepatitis B patients
H. -Y. Pan et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Reliable timescale inference of HBV genotype A origin and phylodynamics
Gianguglielmo Zehender et al.
INFECTION GENETICS AND EVOLUTION (2015)
Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study
Wai-Kay Seto et al.
GUT (2015)
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B
Pietro Lampertico et al.
GUT (2013)
Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2012)
Hepatitis B therapy
Hellan Kwon et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Robust Hepatitis B Virus Genotyping by Mass Spectrometry
L. Ganova-Raeva et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Factors That Predict Response of Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B to Peginterferon-Alfa
Erik H. C. J. Buster et al.
GASTROENTEROLOGY (2009)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Treatment with Peg-interferon α-2b for HBeAg-positive chronic hepatitis B:: HBsAg loss is associated with HBV genotype
HJ Flink et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised
HLA Janssen et al.
LANCET (2005)
Share Paper
